Clinical Trial Update: Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting results from a three-arm study involving Carboplatin, Paclitaxel, and Dacarbazine in advanced melanoma, focusing on drug-drug int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Dacarbazine (dacarbazine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2014-01-06